Multimedica is a research and cure institute that operates in the prevention and cure of different degenerative diseases. Recently their activities are related to the Tumor, Diabete and Cardiological diseases prevention.
ISB & Multimedica collaboration activities: The center collaborate with ISB since different years and recently are developing new approaches for prostate cancer, diabete prevention and related therapeutic monitoring (Albini A., Noonan D. Cristoni S. et al. Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach. Front. 29 Endocrinol. 05 April 2018 | https://doi.org/10.3389/fendo.2018.00110, RossiBernardi L., Cristoni S. Analysis of glycopeptides for diabete prevention. Pending). One of the main project followed by Multimedica is the validation of SANIST technological platform (Albini A. et al. SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers. Rapid Commun Mass Spectrom.2015 Oct 15;29(19):1703-10. doi: 10.1002/rcm.7270 ; Cristoni et al. SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses. J Mass Spectrom. 2017 Jan;52(1):16-21. doi: 10.1002/jms.3895 ).